Article Versions Notes

Li M, Wang Y-R, Wang X, Xiao X-L, Sun Y-H, Zhang S-A, Dang Y-Q, Wang K, Zhou W-J. Emodin Enhances Rosiglitazone’s Therapeutic Profile by Dual Modulation of SREBP1-Mediated Adipogenesis and PPARγ-Driven Thermogenesis. Pharmaceuticals. 2025; 18(12):1810. https://doi.org/10.3390/ph18121810

Li, Meng, Yi-Rong Wang, Xue Wang, Xiao-Li Xiao, Yun-Hong Sun, Sheng-An Zhang, Yan-Qi Dang, Kai Wang, and Wen-Jun Zhou. 2025. "Emodin Enhances Rosiglitazone’s Therapeutic Profile by Dual Modulation of SREBP1-Mediated Adipogenesis and PPARγ-Driven Thermogenesis" Pharmaceuticals 18, no. 12: 1810. https://doi.org/10.3390/ph18121810

Li, M., Wang, Y.-R., Wang, X., Xiao, X.-L., Sun, Y.-H., Zhang, S.-A., Dang, Y.-Q., Wang, K., & Zhou, W.-J. (2025). Emodin Enhances Rosiglitazone’s Therapeutic Profile by Dual Modulation of SREBP1-Mediated Adipogenesis and PPARγ-Driven Thermogenesis. Pharmaceuticals, 18(12), 1810. https://doi.org/10.3390/ph18121810